Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patients
Bravo, R.; Soriano, V.; García-Samaniego, J.; Gómez-Cano, M.; González-Lahoz, J.; Altisent, C.; Ruiz, I.
Antiviral Therapy 1(3): 194
1996
ISSN/ISBN: 1359-6535 PMID: 11322254 Document Number: 465110
Document emailed within 1 workday
Related Documents
Mihăilescu, R.; Arama, V.; Paraschiv, S.; Streinu-Cercel, A.; Oţelea, D.; Munteanu, D.; Iosipenco, M.; Chiotan, C.; Benea, O.E.; Mărdărescu, M.; Rădulescu, M.; Hristea, A.; Ungurianu, R.; Aramă, S.S.; Cercel, A.S.; Călin, R.; Băicuş, C. 2008: Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy Romanian Journal of Internal Medicine 46(4): 305-311Fox, R.; Gourlay, Y.J. 2000: The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow Health Bulletin 58(4): 309-315
Paul, S.; Gilbert, H.M.; Lande, L.; Vaamonde, C.M.; Jacobs, J.; Malak, S.; Sepkowitz, K.A. 2002: Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001 Aids Research and Human Retroviruses 18(7): 501-506
Soriano, V.; Rivas, P.; Nuñez, M. 2008: Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(11): 1486-1489
Geng, E.H.; Glidden, D.V.; Emenyonu, N.; Musinguzi, N.; Bwana, M.B.; Neilands, T.B.; Muyindike, W.; Yiannoutsos, C.T.; Deeks, S.G.; Bangsberg, D.R.; Martin, J.N. 2010: Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa Tropical Medicine and International Health: Tm and Ih 15(Suppl 1): 63-69
Baiocchi, O.C.G.; Colleoni, G.W.B.; Navajas, E.V.; Duarte, L.Claudio.C.; Alves, A.C.; Andrade, A.Lucia.S.S.; Kerbauy, J.; Oliveira, J.Salvador.R. 2002: Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma Acta Oncologica 41(2): 192-196
Kaye, D.K.; Kakaire, O.; Osinde, M.O.; Lule, J.C.; Kakande, N. 2013: The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa Journal of Infection in Developing Countries 7(6): 436-447
Guo, F.-p.; Yu, X.-b.; Luo, L.; Han, Y.; Qiu, Z.-f.; Zuo, L.-y.; Li, Y.-l.; Yu, W.; Li, T.-s. 2010: The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients Zhonghua Nei Ke Za Zhi 49(8): 649-652
Pasquet, A.; Messou, E.èn.; Gabillard, D.; Minga, A.; Depoulosky, A.; Deuffic-Burban, S.; Losina, E.; Freedberg, K.A.; Danel, C.; Anglaret, X.; Yazdanpanah, Y. 2010: Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire Plos one 5(10): E13414
Page, I.D.; McKew, S.J.; Kudzala, A.G.; Fullwood, C.; van Oosterhout, J.J.; Bates, I. 2013: Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy International Journal of Std and Aids 24(6): 449-453
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Bunupuradah, T.; Kosalaraksa, P.; Vibol, U.; Hansudewechakul, R.; Sophonphan, J.; Kanjanavanit, S.; Ngampiyaskul, C.; Wongsawat, J.; Luesomboon, W.; Vonthanak, S.; Ananworanich, J.; Ruxrungtham, K.; Puthanakit, T.; Phanuphak, P.; Cooper, D.A.; Kaldor, J.; Vun, M.C.; Vonthanak, S.; Ruxrungtham, K.; Giaquinto, C.; Cotton, M.; Lolekha, R.; Sirisanthana, V.; Chokephaibulkit, K.; Suntarattiwong, P.; Volberding, P.; Bangdiwala, S.; Lim, K.; Samuel, N.M.; Schoenfeld, D.; Sohn, A.H.; Solomon, S.; Suwangool, P.; Wang, R.; Zhang, F.; Zoloth, L.; Dixon, D.O.; Fox, L.; Ojumu, A.O.; Bupp, J.E.; Ussery, M.; Wetherall, N.T.; Brouwers, P.; Mofenson, L.M.; Douoguih, M.; Law, M.; Shearer, W.T.; Valcour, V.; Paul, R.; Pattanapanyasat, K.; Sakulploy, N.; McNic 2013: Impact of antiretroviral therapy on quality of life in HIV-infected Southeast Asian children in the PREDICT study Aids Patient Care and Stds 27(11): 596-603
Bepe, N.; Madanhi, N.; Mudzviti, T.; Gavi, S.; Maponga, C.C.; Morse, G.D. 2011: The impact of herbal remedies on adverse effects and quality of life in HIV-infected individuals on antiretroviral therapy Journal of Infection in Developing Countries 5(1): 48-53
Peters, P.James.; McNicholl, J.M.; Raengsakulrach, B.; Wasinrapee, P.; Mueanpai, F.; Ratanasuwan, W.; Intalapaporn, P.; Drobeniuc, J.; Ramachandran, S.; Thai, H.; Xia, G-Liang.; Kamili, S.; Khudyakov, Y.; Weidle, P.J.; Teo, C.Gee.; McConnell, M.S. 2013: An evaluation of hepatitis B virus diagnostic methods and responses to antiretroviral therapy among HIV-infected women in Thailand Journal of the International Association of Providers of Aids Care 12(5): 349-353
Kakinami, L.; de Bruyn, G.; Pronyk, P.; Mohapi, L.; Tshabangu, N.; Moshabela, M.; McIntyre, J.; Martinson, N.A. 2011: The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa Aids and Behavior 15(4): 823-831
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Prasitsuebsai, W.; Kariminia, A.; Puthanakit, T.; Lumbiganon, P.; Hansudewechakul, R.; Siew Moy, F.; Law, M.; Kumarasamy, N.; Razali, K.; Sirisanthana, V.; Sohn, A.H.; Chokephaibulkit, K. 2014: Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database Pediatric Infectious Disease Journal 33(7): 747-752
Prasitsuebsai, W.; Kariminia, A.; Puthanakit, T.; Lumbiganon, P.; Hansudewechakul, R.; Siew Moy, F.; Law, M.; Kumarasamy, N.; Razali, K.; Sirisanthana, V.; Sohn, A.H.; Chokephaibulkit, K. 2014: Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database Pediatric Infectious Disease Journal 33(7): 747-752
Kundro, M.A.; Viloria, G.A.; Toibaro, J.J.; Losso, M.H. 2017: Antiretroviral therapy and arterial elasticity in HIV-infected patients Medicina 77(5): 365-369